China genomics giant BGI targets A-share IPO

BGI, one of the world’s largest genome sequencing firms, plans to list in China to help fund growth and acquisitions but it is unclear if the IPO will see light in 2016.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES